Actieve functies van Maureen Deehan
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Vivtex Corp. | Algemeen Directeur | 21-02-2023 | - |
| Operationeel Directeur | 01-12-2022 | 21-02-2023 |
Loopbaan van Maureen Deehan
Eerdere bekende functies van Maureen Deehan
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| THOR MEDICAL | Corporate Officer/Principal | 01-06-2018 | - |
Opleiding van Maureen Deehan
| University of Strathclyde | Undergraduate Degree |
| University of Glasgow School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigd Koninkrijk | 3 |
| Noorwegen | 2 |
| Verenigde Staten | 2 |
Operationeel
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Nordic Nanovector ASA
 Nordic Nanovector ASA Pharmaceuticals: MajorHealth Technology Nordic Nanovector ASA is a biopharmaceutical company, which engages in the development, marketing, and sale of medical products and equipment for anticancer therapeutics for haematological cancers. The firm offers the Betalutin which is an antibody radionuclide conjugates for the treatment of non-Hodgkin lymphoma. It operates through the following geographical segments: Norway, Switzerland, and the United Kingdom. The company was founded by Roy Hartvig Larsen, Oyvind Sverre Bruland, and Jostein Dahle on July 2, 2009 and is headquartered in Oslo, Norway. | Health Technology |
| Vivtex Corp. |
- Beurs
- Insiders
- Maureen Deehan
- Ervaring
